Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2022 Filed May 12, 2022 20:01 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-028523 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:01 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-028523 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,564 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:01 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 300 | $17.26 | $5,176.50 |
DisclosureSEC source: 0001209191-22-028523 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.245 to $17.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:01 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,096 | $16.42 | $83,687.02 |
DisclosureSEC source: 0001209191-22-028523 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,153 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.24 to $17.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:01 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-028523 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 21:59 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-026307 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,960 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 21:59 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $18.30 | $98,736.55 |
DisclosureSEC source: 0001209191-22-026307 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.095 to $18.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 21:59 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-026307 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 21:59 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-026307 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,356 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 21:59 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $18.68 | $100,773.00 |
DisclosureSEC source: 0001209191-22-026307 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.35 to $19.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 21:59 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-026307 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 22, 2022 Filed Apr 25, 2022 22:47 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 26,789 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025550 · doc4.xml · derivative · entry 7 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,637 Underlying: Common Stock · 26,789 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and fully vested on April 27, 2021. Read SEC document |
| April 22, 2022 Filed Apr 25, 2022 22:47 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 26,789 | $20.00 | $535,780.00 |
DisclosureSEC source: 0001209191-22-025550 · doc4.xml · nonDerivative · entry 5 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,211 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 22, 2022 Filed Apr 25, 2022 22:47 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 26,789 | $1.00 | $26,789.00 |
DisclosureSEC source: 0001209191-22-025550 · doc4.xml · nonDerivative · entry 4 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 22:47 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 79,568 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025550 · doc4.xml · derivative · entry 6 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589,426 Underlying: Common Stock · 79,568 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and fully vested on April 27, 2021. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 22:47 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 9,744 | $21.35 | $207,988.60 |
DisclosureSEC source: 0001209191-22-025550 · doc4.xml · nonDerivative · entry 3 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,211 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.00 to $21.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 22:47 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 69,824 | $20.43 | $1,426,183.13 |
DisclosureSEC source: 0001209191-22-025550 · doc4.xml · nonDerivative · entry 2 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,955 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 22:47 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 79,568 | $1.00 | $79,568.00 |
DisclosureSEC source: 0001209191-22-025550 · doc4.xml · nonDerivative · entry 1 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:05 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 106,357 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025160 · doc4.xml · derivative · entry 6 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668,994 Underlying: Common Stock · 106,357 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and fully vested on April 27, 2021. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:05 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 106,357 | $22.34 | $2,376,015.38 |
DisclosureSEC source: 0001209191-22-025160 · doc4.xml · nonDerivative · entry 4 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,211 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.76 to $22.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:05 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 106,357 | $1.00 | $106,357.00 |
DisclosureSEC source: 0001209191-22-025160 · doc4.xml · nonDerivative · entry 3 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 6,296 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-025028 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,752 Underlying: Common Stock · 6,296 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 6,296 | $22.14 | $139,393.44 |
DisclosureSEC source: 0001209191-22-025028 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.94 to $23.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 19, 2022 Filed Apr 20, 2022 21:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 6,296 | $4.49 | $28,269.04 |
DisclosureSEC source: 0001209191-22-025028 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 20:05 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 106,357 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025160 · doc4.xml · derivative · entry 5 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775,351 Underlying: Common Stock · 106,357 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and fully vested on April 27, 2021. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 20:05 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
SaleCommon Stock | 106,357 | $22.74 | $2,418,558.18 |
DisclosureSEC source: 0001209191-22-025160 · doc4.xml · nonDerivative · entry 2 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,211 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.90 to $23.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 20:05 UTC |
Desai VeeralChief Strategy & Dev. Officer
|
Exercise / conversionCommon Stock | 106,357 | $1.00 | $106,357.00 |
DisclosureSEC source: 0001209191-22-025160 · doc4.xml · nonDerivative · entry 1 Desai Veeral · CIK 0001855973 · Chief Strategy & Dev. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 19, 2022 Filed Apr 29, 2022 22:01 UTC Amendment |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 6,296 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-026309 · doc4a.xml · derivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525,752 Underlying: Common Stock · 6,296 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 21:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 6,477 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-025028 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,048 Underlying: Common Stock · 6,477 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 21:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 6,477 | $22.64 | $146,639.28 |
DisclosureSEC source: 0001209191-22-025028 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.57 to $23.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 21:02 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 6,477 | $4.49 | $29,081.73 |
DisclosureSEC source: 0001209191-22-025028 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 18, 2022 Filed Apr 29, 2022 22:01 UTC Amendment |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 6,477 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-026309 · doc4a.xml · derivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,048 Underlying: Common Stock · 6,477 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 21:00 UTC |
Venkatachaliah GirishChief Technology Officer
|
GrantOptions (Rights to Buy) · Derivative | 35,664 | $0.00 Strike: $23.07 | $0.00 |
DisclosureSEC source: 0001209191-22-025024 · doc4.xml · derivative · entry 2 Venkatachaliah Girish · CIK 0001855795 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,664 Underlying: Common Stock · 35,664 shares Expires 2032-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 21:00 UTC |
Venkatachaliah GirishChief Technology Officer
|
GrantCommon Stock | 10,837 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025024 · doc4.xml · nonDerivative · entry 1 Venkatachaliah Girish · CIK 0001855795 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,271 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 16:57 UTC |
Sell StevenDirector · CEO & President
|
GrantOptions (Rights to Buy) · Derivative | 160,486 | $0.00 Strike: $23.07 | $0.00 |
DisclosureSEC source: 0001209191-22-025019 · doc4.xml · derivative · entry 2 Sell Steven · CIK 0001479123 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,486 Underlying: Common Stock · 160,486 shares Expires 2032-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 16:57 UTC |
Sell StevenDirector · CEO & President
|
GrantCommon Stock | 48,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025019 · doc4.xml · nonDerivative · entry 1 Sell Steven · CIK 0001479123 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,765 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:56 UTC |
Mansukani SharadDirector
|
GrantCommon Stock | 6,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025015 · doc4.xml · nonDerivative · entry 1 Mansukani Sharad · CIK 0001402190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,236,292 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 21:00 UTC |
WILLIAMS RONALD ADirector
|
GrantCommon Stock | 6,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025026 · doc4.xml · nonDerivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,458,792 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 16:58 UTC |
SMITH MICHAEL LDirector
|
GrantCommon Stock | 6,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025021 · doc4.xml · nonDerivative · entry 1 SMITH MICHAEL L · CIK 0001194201 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,992 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:56 UTC |
McLoughlin KarenDirector
|
GrantCommon Stock | 6,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025017 · doc4.xml · nonDerivative · entry 1 McLoughlin Karen · CIK 0001541704 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,425 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 16:53 UTC |
Bensley TimothyChief Financial Officer
|
GrantOptions (Rights to Buy) · Derivative | 44,580 | $0.00 Strike: $23.07 | $0.00 |
DisclosureSEC source: 0001209191-22-025008 · doc4.xml · derivative · entry 2 Bensley Timothy · CIK 0001740653 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,580 Underlying: Common Stock · 44,580 shares Expires 2032-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 16:53 UTC |
Bensley TimothyChief Financial Officer
|
GrantCommon Stock | 13,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025008 · doc4.xml · nonDerivative · entry 1 Bensley Timothy · CIK 0001740653 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,491 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 21:01 UTC |
Wulf John WilliamDirector
|
GrantCommon Stock | 6,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025027 · doc4.xml · nonDerivative · entry 1 Wulf John William · CIK 0001856345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,392 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:59 UTC |
Sobotka GlennChief Accounting Officer
|
GrantOptions (Rights to Buy) · Derivative | 8,025 | $0.00 Strike: $23.07 | $0.00 |
DisclosureSEC source: 0001209191-22-025022 · doc4.xml · derivative · entry 2 Sobotka Glenn · CIK 0001855927 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,025 Underlying: Common Stock · 8,025 shares Expires 2032-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:59 UTC |
Sobotka GlennChief Accounting Officer
|
GrantCommon Stock | 2,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025022 · doc4.xml · nonDerivative · entry 1 Sobotka Glenn · CIK 0001855927 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,699 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:57 UTC |
Richards ClayDirector
|
GrantCommon Stock | 6,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025018 · doc4.xml · nonDerivative · entry 1 Richards Clay · CIK 0001855965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,592 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:58 UTC |
Shaker BenjaminChief Markets Officer
|
GrantOptions (Rights to Buy) · Derivative | 44,580 | $0.00 Strike: $23.07 | $0.00 |
DisclosureSEC source: 0001209191-22-025020 · doc4.xml · derivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,580 Underlying: Common Stock · 44,580 shares Expires 2032-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:58 UTC |
Shaker BenjaminChief Markets Officer
|
GrantCommon Stock | 13,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025020 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,456 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:55 UTC |
Gourdine Michelle ADirector
|
GrantCommon Stock | 6,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025011 · doc4.xml · nonDerivative · entry 1 Gourdine Michelle A · CIK 0001855956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,892 F1 · shares: Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2022 Filed Apr 20, 2022 20:55 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
GrantOptions (Rights to Buy) · Derivative | 17,832 | $0.00 Strike: $23.07 | $0.00 |
DisclosureSEC source: 0001209191-22-025013 · doc4.xml · derivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,832 Underlying: Common Stock · 17,832 shares Expires 2032-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.